Primus In News
Budget 2022: Pharma sector wants tax breaks, R&D incentives
29-01-2022
Anurag Singh, managing director of a consulting firm Primus Partners added that a combination of high-impact schemes have been put in place for pharma-sector recently, including PLIs for pharma, key starting materials (KSM), API, medical devices, scheme for promotion of bulk drug parks, medical device parks, etc. The net impact of the pandemic and supply chain disruptions in China have been favourable for the Indian pharma sector.
Explore Related Insights
- Ways Forward In Various Sectors Post The Covid-19: Debate
- Budget 2024 Expectations: Income tax rebate to home loan tax exemption. What ‘aam aadmi’ expects from FM Sitharaman
- Ethanol From Grains May Generate Rs 35,000 Crore In Earnings For Farmers
- Plane-less Go First's situation 'painful'; hopes for tailwind remain muted